Cancer survivors' efforts to facilitate return to work
Gauthier Bellagamba1,2, Aymeric Descamps3, Cathia Cypowyj3
1Aix-Marseille Univ, CEReSS 3279, Marseille, France.
Psychology, Health & Medicine
|July 23, 2020
Summary
Cancer survivors who maintain company contact during sick leave are more likely to return to work sooner. Early discussions about treatment adaptation can lead to changes in job conditions, aiding recovery.
Area of Science:
- Occupational Health
- Oncology
- Rehabilitation Medicine
Background:
- Return to work (RTW) is a critical aspect of recovery for cancer survivors.
- Understanding factors influencing RTW is essential for supporting survivors' reintegration into the workforce.
- Individual and occupational factors play a significant role in the success of job resumption after cancer treatment.
Purpose of the Study:
- To identify individual factors influencing return to work (RTW) in cancer survivors.
- To explore how job resumption preparation impacts cancer survivors' ability to return to work.
- To compare different methods of returning to work based on occupational and medical characteristics.
Main Methods:
- A self-administered questionnaire was used to collect data from 105 cancer survivors.
- Data were collected at least 4 weeks after the participants' return to work.
- Multivariate statistical tests were employed to compare various RTW methods with occupational and medical characteristics.
Main Results:
- Regular contact with the company during sick leave was associated with RTW within 1 year of diagnosis (OR=5.78).
- An optional pre-reinstatement visit with an occupational physician correlated with no change in employee activity (OR=2.30).
- Cancer survivors requesting treatment adaptation during therapy were more likely to experience changes in working conditions (OR=14.5).
Conclusions:
- Adaptation to recovery conditions appears linked to survivors' efforts towards RTW.
- Proactive communication and workplace adjustments are crucial for successful cancer survivor reintegration.
- Further research is recommended to confirm these findings and explore intervention strategies.
Related Concept Videos
Cancer Survival Analysis
568
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
568
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Vaccines
861
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
861
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Classification of Illness
8.4K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.4K
Tumor Immunotherapy
1.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K


